Spironolactone Tablet, Coated
Product Images NDC 70518-3625

11 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-3625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure diagram of spironolactone, illustrating the molecular arrangement and bonds of the active ingredient spironolactone in the product.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve chart showing probability over time in months for two groups: Spironolactone (n=822) and Placebo (n=841). The chart illustrates a statistically significant difference with a log-rank p-value less than 0.001, indicating differing survival probabilities between the groups over approximately 36 months.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot diagram illustrating hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups related to Spironolactone treatment compared to placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA classification, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot shows the comparative effectiveness with direction indicated from Spironolactone better to placebo better.*
FDA Label Image

Mm1 (Spironolactone 25mg 70518 3625 00)

Mm1 (Spironolactone 25mg 70518 3625 00)
Spironolactone 25 mg coated tablets packaging label showing quantity of 30 tablets. The label includes NDC number 70518-3625-00, repackager RemedyRepack Inc. of Indiana, PA, and manufacturer Oxford Pharmaceuticals, LLC, Birmingham, AL. Storage instructions and usual dosage guidance noted. Tablets described as round and white.*
FDA Label Image

Mm2 (Spironolactone 25mg 70518 3625 01)

Mm2 (Spironolactone 25mg 70518 3625 01)
Spironolactone 25 mg coated tablet label indicating a quantity of 100 tablets. The label includes the NDC number 70518-3625-01 and states the tablets are round and white. It also lists the manufacturer as Oxford Pharmaceuticals, LLC, Birmingham, AL, and repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and usual dosage directions are noted.*
FDA Label Image

Mm3 (Spironolactone 25mg 70518 3625 02)

Mm3 (Spironolactone 25mg 70518 3625 02)
Label for Spironolactone Tablet 25 mg oral coated tablets, with a quantity of 90 tablets shown. The label includes the NDC number 70518-3625-02 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Manufacturer details list Oxford Pharmaceuticals, LLC, Birmingham, AL. Storage instructions and dosage direction to see insert are noted.*
FDA Label Image

Mm4 (Spironolactone 25mg 70518 3625 03)

Mm4 (Spironolactone 25mg 70518 3625 03)
Label for Spironolactone 25 mg coated tablets, with a quantity of 30 tablets. The label shows the NDC number 70518-3625-03 and states the tablets are round and white. It lists RemedyRepack Inc. in Indiana, PA as the repackager and Oxford Pharmaceuticals, LLC in Birmingham, AL as the manufacturer. Storage instructions and a note to keep out of reach of children are also included.*
FDA Label Image

Mm5 (Spironolactone 25mg 70518 3625 04)

Mm5 (Spironolactone 25mg 70518 3625 04)
Spironolactone 25 mg coated tablets packaging label showing quantity of 100 tablets per box. The label includes NDC number 70518-3625-04 and manufacturer info noting repackaging by RemedyRepack Inc., Indiana, PA. Instructions mention usual dosage is in the insert and storage temperature guidelines are provided.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Spironolactone 25 mg coated tablets packaging label from RemedyRepack Inc. The label shows a quantity of 30 tablets and lists the manufacturer as Oxford Pharmaceuticals, LLC. The label includes barcode, QR code, NDC 70518-3625-00, and storage instructions, advising to keep medication out of the reach of children.*
FDA Label Image

Mm7 (Spironolactone 25mg 70518 3625 06)

Mm7 (Spironolactone 25mg 70518 3625 06)
Label for Spironolactone Tablet 25 mg coated tablets. The label states a quantity of 30 tablets with an NDC of 70518-3625-06. It is repackaged by RemedyRepack Inc., Indiana, PA. The original manufacturer is Oxford Pharmaceuticals, LLC, Birmingham, AL. Storage instructions and usual dosage guidance are partially visible.*
FDA Label Image

Mm8 (Spironolactone 25mg 70518 3625 07)

Mm8 (Spironolactone 25mg 70518 3625 07)
Spironolactone 25 mg tablet label showing quantity of 100 tablets. The label specifies the drug as round white tablets and includes NDC number 70518-3625-07. It is repackaged by RemedyRepack Inc., Indiana, PA. Manufacturing information from Oxford Pharmaceuticals, LLC, Birmingham, AL is also included alongside storage instructions and caution to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.